Think GLP-1s Are Too Expensive for Your Health Plan? Cutting Them Might Hurt Your Bottom Line
Summary
A new study reveals that dropping coverage for weight-loss drugs like Ozempic could backfire—costing companies up to $866 per worker in lost productivity.
Visit the original source for the full article
